Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 341 - 360 of 480 trials
Titlesort icon Investigator Disease(s)
A Phase III Study of Inotuzumab Ozogamicin versus Standard Therapy in Patients with Persistent or Recurrent CD22-Positive Acute Lymphoblastic Leukemia
Relapsed/Refractory
[Protocol 12-262]
Park, Jae
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase III Study of KW-0761 versus Vorinostat in Patients with Previously Treated Cutaneous T-Cell Lymphoma
[Protocol 13-007]
Moskowitz, Alison
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Lenalidomide, Bortezomib, and Dexamethasone Combination Treatment with or without Peripheral Stem Cell Transplantation in the Initial Management of Multiple Myeloma
Newly Diagnosed
[Protocol 12-018]
Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase III Study of MEK162 versus Dacarbazine in Patients with Inoperable or Metastatic Melanomas with NRAS Q61 Mutations: The NEMO Trial
[Protocol 13-083]
Postow, Michael
  • Melanoma
A Phase III Study of MEK162 versus Standard Chemotherapy in Patients with Recurrent or Persistent Low-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: The MILO Study
[Protocol 13-098]
Grisham, Rachel
  • Ovarian Cancer
A Phase III Study of Multimodality Therapy for Extra-ocular Retinoblastoma
[Protocol 08-072]
Dunkel, Ira
  • Retinoblastoma
A Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
[Protocol 07-041]
Eastham, James
  • Prostate Cancer
    • Localized Disease
A Phase III Study of Nivolumab and Ipilimumab, Together and Individually, in Patients Newly Diagnosed with Advanced Melanoma
[Protocol 13-075]
Wolchok, Jedd
  • Melanoma
A Phase III Study of Ofatumumab versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Relapsed/Refractory
[Protocol 11-079]
Matasar, Matthew
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Olaparib vs Placebo as Maintenance Therapy in Women with BRCA-Mutated Advanced Ovarian Cancer After Platinum-Based Chemotherapy
[Protocol 14-036]
Bell-McGuinn, Katherine
  • Ovarian Cancer
A Phase III Study of Postoperative Radiation Therapy with and without Cetuximab for Locally Advanced Resected Head and Neck Cancer
[Protocol 10-081]
Lee, Nancy
  • Head & Neck Cancer
A Phase III Study of Rituximab/Lenalidomide or Rituximab/Chemotherapy Followed by Rituximab Maintenance Therapy in Patients with Previously Untreated Follicular Lymphoma
Newly Diagnosed
[Protocol 12-081]
Palomba, M. Lia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Ruxolitinib versus Hydroxyurea to Treat Symptoms of Polycythemia Vera: the RELIEF Study
[Protocol 13-142]
Rampal, Raajit
  • Hematology
    • Hematologic Disorders
A Phase III Study of Sapacitabine in Elderly Patients Newly Diagnosed with Acute Myeloid Leukemia
Newly Diagnosed
[Protocol 12-034]
Berman, Ellin
  • Geriatrics
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase III Study of Sorafenib Alone versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Patients with Liver Cancer
[Protocol 13-250]
Goodman, Karyn
  • Hepatobiliary
    • Liver Cancer
A Phase III Study of Sorafenib plus Doxorubicin versus Sorafenib Alone in Patients with Advanced Hepatocellular Cancer
[Protocol 11-039]
Abou-Alfa, Ghassan
  • Hepatobiliary
    • Liver Cancer
A Phase III Study of Standard Chemotherapy with and without Rilotumumab as Initial Treatment in Patients with Metastatic or Inoperable Gastric/Esophageal Cancer
[Protocol 13-091]
Ilson, David
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase III Study of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
[Protocol 11-190]
King, Tari
  • Breast Cancer
A Phase III Study of Vandetanib in Patients with Locally Advanced or Metastatic Papillary Thyroid Cancer Who Cannot Be Successfully Treated with Radioiodine
[Protocol 13-245]
Sherman, Eric
  • Thyroid Cancer
A Phase III Study of Vemurafenib in Patients with Surgically Removed BRAF-Mutant Melanoma Who Have a High Risk of Recurrence
[Protocol 12-166]
Chapman, Paul
  • Melanoma